Increased expression of PTGS2 and production of PGE2 are found in many solid tumours, including HNSCC, and correlate with tumour stage, metastasis and worse clinical outcome, whilst low levels are associated with better response to chemotherapy [16,17]. This evidence concerns the gene PTGS2 and head and neck squamous cell carcinoma.